nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.209	0.253	CbGbCtD
Ceftizoxime—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.186	0.225	CbGbCtD
Ceftizoxime—SLC15A1—Ramipril—type 2 diabetes mellitus	0.166	0.201	CbGbCtD
Ceftizoxime—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.159	0.192	CbGbCtD
Ceftizoxime—SLC15A1—Glyburide—type 2 diabetes mellitus	0.107	0.129	CbGbCtD
Ceftizoxime—Erythema multiforme—Repaglinide—type 2 diabetes mellitus	0.000953	0.00553	CcSEcCtD
Ceftizoxime—Cellulitis—Losartan—type 2 diabetes mellitus	0.000938	0.00544	CcSEcCtD
Ceftizoxime—Pancytopenia—Glimepiride—type 2 diabetes mellitus	0.000924	0.00536	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Gliclazide—type 2 diabetes mellitus	0.000923	0.00535	CcSEcCtD
Ceftizoxime—Erythema multiforme—Rosiglitazone—type 2 diabetes mellitus	0.000901	0.00522	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.000884	0.00513	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.000875	0.00507	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.000875	0.00507	CcSEcCtD
Ceftizoxime—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.000867	0.00503	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Glimepiride—type 2 diabetes mellitus	0.00086	0.00498	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Sitagliptin—type 2 diabetes mellitus	0.000857	0.00497	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Irbesartan—type 2 diabetes mellitus	0.000851	0.00493	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.00084	0.00487	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Glipizide—type 2 diabetes mellitus	0.00083	0.00481	CcSEcCtD
Ceftizoxime—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.000809	0.00469	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Losartan—type 2 diabetes mellitus	0.000801	0.00464	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Pioglitazone—type 2 diabetes mellitus	0.000795	0.00461	CcSEcCtD
Ceftizoxime—Eosinophilia—Glyburide—type 2 diabetes mellitus	0.000794	0.0046	CcSEcCtD
Ceftizoxime—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.000786	0.00456	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Sitagliptin—type 2 diabetes mellitus	0.000772	0.00448	CcSEcCtD
Ceftizoxime—Anaemia—Rosiglitazone—type 2 diabetes mellitus	0.000767	0.00445	CcSEcCtD
Ceftizoxime—Pancytopenia—Glyburide—type 2 diabetes mellitus	0.000762	0.00442	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Gliclazide—type 2 diabetes mellitus	0.00075	0.00435	CcSEcCtD
Ceftizoxime—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000747	0.00433	CcSEcCtD
Ceftizoxime—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.000742	0.00431	CcSEcCtD
Ceftizoxime—Erythema multiforme—Glimepiride—type 2 diabetes mellitus	0.000736	0.00427	CcSEcCtD
Ceftizoxime—Erythema multiforme—Sitagliptin—type 2 diabetes mellitus	0.000734	0.00425	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Irbesartan—type 2 diabetes mellitus	0.000729	0.00423	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.000716	0.00415	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.000701	0.00407	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Bromocriptine—type 2 diabetes mellitus	0.000699	0.00405	CcSEcCtD
Ceftizoxime—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.000695	0.00403	CcSEcCtD
Ceftizoxime—Rash—Miglitol—type 2 diabetes mellitus	0.000688	0.00399	CcSEcCtD
Ceftizoxime—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000688	0.00399	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	0.000686	0.00398	CcSEcCtD
Ceftizoxime—Pancytopenia—Gliclazide—type 2 diabetes mellitus	0.000684	0.00397	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.000677	0.00393	CcSEcCtD
Ceftizoxime—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.000667	0.00387	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.000663	0.00384	CcSEcCtD
Ceftizoxime—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000651	0.00378	CcSEcCtD
Ceftizoxime—Leukopenia—Glipizide—type 2 diabetes mellitus	0.00065	0.00377	CcSEcCtD
Ceftizoxime—Nausea—Miglitol—type 2 diabetes mellitus	0.000649	0.00376	CcSEcCtD
Ceftizoxime—Paraesthesia—Repaglinide—type 2 diabetes mellitus	0.000643	0.00373	CcSEcCtD
Ceftizoxime—Anaemia—Pioglitazone—type 2 diabetes mellitus	0.000643	0.00373	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.000637	0.00369	CcSEcCtD
Ceftizoxime—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000632	0.00367	CcSEcCtD
Ceftizoxime—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000632	0.00366	CcSEcCtD
Ceftizoxime—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000632	0.00366	CcSEcCtD
Ceftizoxime—Anaemia—Glimepiride—type 2 diabetes mellitus	0.000626	0.00363	CcSEcCtD
Ceftizoxime—Rash—Tolbutamide—type 2 diabetes mellitus	0.000619	0.00359	CcSEcCtD
Ceftizoxime—Neutropenia—Valsartan—type 2 diabetes mellitus	0.000619	0.00359	CcSEcCtD
Ceftizoxime—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000611	0.00354	CcSEcCtD
Ceftizoxime—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00061	0.00354	CcSEcCtD
Ceftizoxime—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000607	0.00352	CcSEcCtD
Ceftizoxime—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000605	0.00351	CcSEcCtD
Ceftizoxime—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000599	0.00347	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.000592	0.00344	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	0.000588	0.00341	CcSEcCtD
Ceftizoxime—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000587	0.0034	CcSEcCtD
Ceftizoxime—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000587	0.0034	CcSEcCtD
Ceftizoxime—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000585	0.0034	CcSEcCtD
Ceftizoxime—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000583	0.00338	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.00058	0.00336	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Gliclazide—type 2 diabetes mellitus	0.000574	0.00333	CcSEcCtD
Ceftizoxime—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000568	0.00329	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000568	0.00329	CcSEcCtD
Ceftizoxime—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000566	0.00328	CcSEcCtD
Ceftizoxime—Neutropenia—Metformin—type 2 diabetes mellitus	0.000563	0.00327	CcSEcCtD
Ceftizoxime—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000563	0.00327	CcSEcCtD
Ceftizoxime—Rash—Tolazamide—type 2 diabetes mellitus	0.000563	0.00327	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000558	0.00323	CcSEcCtD
Ceftizoxime—Rash—Linagliptin—type 2 diabetes mellitus	0.000557	0.00323	CcSEcCtD
Ceftizoxime—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000557	0.00323	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000553	0.00321	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000551	0.0032	CcSEcCtD
Ceftizoxime—Vomiting—Acarbose—type 2 diabetes mellitus	0.000546	0.00316	CcSEcCtD
Ceftizoxime—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.000545	0.00316	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000541	0.00314	CcSEcCtD
Ceftizoxime—Rash—Acarbose—type 2 diabetes mellitus	0.000541	0.00314	CcSEcCtD
Ceftizoxime—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000541	0.00313	CcSEcCtD
Ceftizoxime—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.000532	0.00309	CcSEcCtD
Ceftizoxime—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000532	0.00309	CcSEcCtD
Ceftizoxime—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000532	0.00308	CcSEcCtD
Ceftizoxime—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000531	0.00308	CcSEcCtD
Ceftizoxime—Nausea—Tolazamide—type 2 diabetes mellitus	0.000531	0.00308	CcSEcCtD
Ceftizoxime—Eosinophilia—Losartan—type 2 diabetes mellitus	0.00053	0.00307	CcSEcCtD
Ceftizoxime—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00053	0.00307	CcSEcCtD
Ceftizoxime—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.00053	0.00307	CcSEcCtD
Ceftizoxime—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000528	0.00306	CcSEcCtD
Ceftizoxime—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000526	0.00305	CcSEcCtD
Ceftizoxime—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000526	0.00305	CcSEcCtD
Ceftizoxime—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000523	0.00303	CcSEcCtD
Ceftizoxime—Rash—Nateglinide—type 2 diabetes mellitus	0.000522	0.00303	CcSEcCtD
Ceftizoxime—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000521	0.00302	CcSEcCtD
Ceftizoxime—Anaemia—Glyburide—type 2 diabetes mellitus	0.000517	0.003	CcSEcCtD
Ceftizoxime—Nausea—Acarbose—type 2 diabetes mellitus	0.00051	0.00296	CcSEcCtD
Ceftizoxime—Pain—Glipizide—type 2 diabetes mellitus	0.000507	0.00294	CcSEcCtD
Ceftizoxime—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000507	0.00294	CcSEcCtD
Ceftizoxime—Leukopenia—Glyburide—type 2 diabetes mellitus	0.0005	0.0029	CcSEcCtD
Ceftizoxime—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000497	0.00288	CcSEcCtD
Ceftizoxime—Nausea—Nateglinide—type 2 diabetes mellitus	0.000492	0.00285	CcSEcCtD
Ceftizoxime—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00049	0.00284	CcSEcCtD
Ceftizoxime—Convulsion—Glyburide—type 2 diabetes mellitus	0.000484	0.00281	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.00048	0.00278	CcSEcCtD
Ceftizoxime—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000479	0.00278	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000478	0.00277	CcSEcCtD
Ceftizoxime—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000473	0.00274	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000473	0.00274	CcSEcCtD
Ceftizoxime—Pain—Sitagliptin—type 2 diabetes mellitus	0.000471	0.00273	CcSEcCtD
Ceftizoxime—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000464	0.00269	CcSEcCtD
Ceftizoxime—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000463	0.00269	CcSEcCtD
Ceftizoxime—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000455	0.00264	CcSEcCtD
Ceftizoxime—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000454	0.00263	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000453	0.00263	CcSEcCtD
Ceftizoxime—Rash—Repaglinide—type 2 diabetes mellitus	0.000452	0.00262	CcSEcCtD
Ceftizoxime—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000451	0.00262	CcSEcCtD
Ceftizoxime—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000449	0.0026	CcSEcCtD
Ceftizoxime—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000448	0.0026	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000447	0.00259	CcSEcCtD
Ceftizoxime—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000445	0.00258	CcSEcCtD
Ceftizoxime—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000437	0.00253	CcSEcCtD
Ceftizoxime—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000436	0.00253	CcSEcCtD
Ceftizoxime—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000435	0.00252	CcSEcCtD
Ceftizoxime—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000429	0.00249	CcSEcCtD
Ceftizoxime—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000427	0.00248	CcSEcCtD
Ceftizoxime—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000426	0.00247	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000426	0.00247	CcSEcCtD
Ceftizoxime—Nausea—Repaglinide—type 2 diabetes mellitus	0.000425	0.00247	CcSEcCtD
Ceftizoxime—Pruritus—Glipizide—type 2 diabetes mellitus	0.000419	0.00243	CcSEcCtD
Ceftizoxime—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000418	0.00243	CcSEcCtD
Ceftizoxime—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00041	0.00237	CcSEcCtD
Ceftizoxime—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000407	0.00236	CcSEcCtD
Ceftizoxime—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000406	0.00236	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000406	0.00235	CcSEcCtD
Ceftizoxime—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000405	0.00235	CcSEcCtD
Ceftizoxime—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000405	0.00235	CcSEcCtD
Ceftizoxime—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000402	0.00233	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000401	0.00233	CcSEcCtD
Ceftizoxime—Convulsion—Orlistat—type 2 diabetes mellitus	0.000395	0.00229	CcSEcCtD
Ceftizoxime—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000394	0.00229	CcSEcCtD
Ceftizoxime—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000391	0.00227	CcSEcCtD
Ceftizoxime—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000388	0.00225	CcSEcCtD
Ceftizoxime—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000382	0.00221	CcSEcCtD
Ceftizoxime—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000378	0.00219	CcSEcCtD
Ceftizoxime—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000377	0.00219	CcSEcCtD
Ceftizoxime—Vomiting—Glipizide—type 2 diabetes mellitus	0.000377	0.00218	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000376	0.00218	CcSEcCtD
Ceftizoxime—Rash—Glipizide—type 2 diabetes mellitus	0.000374	0.00217	CcSEcCtD
Ceftizoxime—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000373	0.00216	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000372	0.00216	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000368	0.00214	CcSEcCtD
Ceftizoxime—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000368	0.00213	CcSEcCtD
Ceftizoxime—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000366	0.00212	CcSEcCtD
Ceftizoxime—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000355	0.00206	CcSEcCtD
Ceftizoxime—Nausea—Glipizide—type 2 diabetes mellitus	0.000352	0.00204	CcSEcCtD
Ceftizoxime—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000352	0.00204	CcSEcCtD
Ceftizoxime—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00203	CcSEcCtD
Ceftizoxime—Pain—Gliclazide—type 2 diabetes mellitus	0.00035	0.00203	CcSEcCtD
Ceftizoxime—Rash—Glimepiride—type 2 diabetes mellitus	0.000349	0.00202	CcSEcCtD
Ceftizoxime—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000348	0.00202	CcSEcCtD
Ceftizoxime—Rash—Sitagliptin—type 2 diabetes mellitus	0.000348	0.00202	CcSEcCtD
Ceftizoxime—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000347	0.00201	CcSEcCtD
Ceftizoxime—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000347	0.00201	CcSEcCtD
Ceftizoxime—Anaemia—Losartan—type 2 diabetes mellitus	0.000345	0.002	CcSEcCtD
Ceftizoxime—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000341	0.00198	CcSEcCtD
Ceftizoxime—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000338	0.00196	CcSEcCtD
Ceftizoxime—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000336	0.00195	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000335	0.00195	CcSEcCtD
Ceftizoxime—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000334	0.00194	CcSEcCtD
Ceftizoxime—Leukopenia—Losartan—type 2 diabetes mellitus	0.000334	0.00194	CcSEcCtD
Ceftizoxime—Nausea—Glimepiride—type 2 diabetes mellitus	0.000328	0.0019	CcSEcCtD
Ceftizoxime—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000327	0.0019	CcSEcCtD
Ceftizoxime—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000324	0.00188	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000323	0.00188	CcSEcCtD
Ceftizoxime—Pruritus—Glyburide—type 2 diabetes mellitus	0.000323	0.00187	CcSEcCtD
Ceftizoxime—Pain—Orlistat—type 2 diabetes mellitus	0.000318	0.00184	CcSEcCtD
Ceftizoxime—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000317	0.00184	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000317	0.00184	CcSEcCtD
Ceftizoxime—Rash—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00182	CcSEcCtD
Ceftizoxime—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00182	CcSEcCtD
Ceftizoxime—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000312	0.00181	CcSEcCtD
Ceftizoxime—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000308	0.00178	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000304	0.00176	CcSEcCtD
Ceftizoxime—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000302	0.00175	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000298	0.00173	CcSEcCtD
Ceftizoxime—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000296	0.00172	CcSEcCtD
Ceftizoxime—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000294	0.0017	CcSEcCtD
Ceftizoxime—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00029	0.00168	CcSEcCtD
Ceftizoxime—Vomiting—Glyburide—type 2 diabetes mellitus	0.00029	0.00168	CcSEcCtD
Ceftizoxime—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00029	0.00168	CcSEcCtD
Ceftizoxime—Rash—Glyburide—type 2 diabetes mellitus	0.000288	0.00167	CcSEcCtD
Ceftizoxime—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000287	0.00167	CcSEcCtD
Ceftizoxime—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000286	0.00166	CcSEcCtD
Ceftizoxime—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00028	0.00162	CcSEcCtD
Ceftizoxime—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000277	0.00161	CcSEcCtD
Ceftizoxime—Convulsion—Ramipril—type 2 diabetes mellitus	0.000277	0.00161	CcSEcCtD
Ceftizoxime—Pain—Irbesartan—type 2 diabetes mellitus	0.000277	0.0016	CcSEcCtD
Ceftizoxime—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000274	0.00159	CcSEcCtD
Ceftizoxime—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000273	0.00158	CcSEcCtD
Ceftizoxime—Nausea—Glyburide—type 2 diabetes mellitus	0.000271	0.00157	CcSEcCtD
Ceftizoxime—Pruritus—Valsartan—type 2 diabetes mellitus	0.000266	0.00154	CcSEcCtD
Ceftizoxime—Pruritus—Orlistat—type 2 diabetes mellitus	0.000263	0.00153	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000261	0.00151	CcSEcCtD
Ceftizoxime—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00026	0.00151	CcSEcCtD
Ceftizoxime—Pain—Losartan—type 2 diabetes mellitus	0.00026	0.00151	CcSEcCtD
Ceftizoxime—Rash—Gliclazide—type 2 diabetes mellitus	0.000258	0.0015	CcSEcCtD
Ceftizoxime—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000258	0.0015	CcSEcCtD
Ceftizoxime—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000257	0.00149	CcSEcCtD
Ceftizoxime—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000256	0.00148	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000255	0.00148	CcSEcCtD
Ceftizoxime—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000254	0.00148	CcSEcCtD
Ceftizoxime—Nausea—Gliclazide—type 2 diabetes mellitus	0.000243	0.00141	CcSEcCtD
Ceftizoxime—Pruritus—Metformin—type 2 diabetes mellitus	0.000242	0.00141	CcSEcCtD
Ceftizoxime—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000241	0.00139	CcSEcCtD
Ceftizoxime—Vomiting—Valsartan—type 2 diabetes mellitus	0.000239	0.00139	CcSEcCtD
Ceftizoxime—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000238	0.00138	CcSEcCtD
Ceftizoxime—Rash—Valsartan—type 2 diabetes mellitus	0.000237	0.00138	CcSEcCtD
Ceftizoxime—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000237	0.00137	CcSEcCtD
Ceftizoxime—Vomiting—Orlistat—type 2 diabetes mellitus	0.000236	0.00137	CcSEcCtD
Ceftizoxime—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000234	0.00136	CcSEcCtD
Ceftizoxime—Rash—Orlistat—type 2 diabetes mellitus	0.000234	0.00136	CcSEcCtD
Ceftizoxime—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000234	0.00136	CcSEcCtD
Ceftizoxime—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000234	0.00136	CcSEcCtD
Ceftizoxime—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000229	0.00133	CcSEcCtD
Ceftizoxime—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000224	0.0013	CcSEcCtD
Ceftizoxime—Nausea—Valsartan—type 2 diabetes mellitus	0.000223	0.0013	CcSEcCtD
Ceftizoxime—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000221	0.00128	CcSEcCtD
Ceftizoxime—Nausea—Orlistat—type 2 diabetes mellitus	0.000221	0.00128	CcSEcCtD
Ceftizoxime—Vomiting—Metformin—type 2 diabetes mellitus	0.000218	0.00126	CcSEcCtD
Ceftizoxime—Rash—Metformin—type 2 diabetes mellitus	0.000216	0.00125	CcSEcCtD
Ceftizoxime—Dermatitis—Metformin—type 2 diabetes mellitus	0.000216	0.00125	CcSEcCtD
Ceftizoxime—Pruritus—Losartan—type 2 diabetes mellitus	0.000215	0.00125	CcSEcCtD
Ceftizoxime—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000208	0.00121	CcSEcCtD
Ceftizoxime—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000206	0.0012	CcSEcCtD
Ceftizoxime—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000206	0.00119	CcSEcCtD
Ceftizoxime—Rash—Irbesartan—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Ceftizoxime—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Ceftizoxime—Nausea—Metformin—type 2 diabetes mellitus	0.000204	0.00118	CcSEcCtD
Ceftizoxime—Vomiting—Losartan—type 2 diabetes mellitus	0.000193	0.00112	CcSEcCtD
Ceftizoxime—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Ceftizoxime—Nausea—Irbesartan—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Ceftizoxime—Rash—Losartan—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Ceftizoxime—Dermatitis—Losartan—type 2 diabetes mellitus	0.000192	0.00111	CcSEcCtD
Ceftizoxime—Pruritus—Ramipril—type 2 diabetes mellitus	0.000185	0.00107	CcSEcCtD
Ceftizoxime—Nausea—Losartan—type 2 diabetes mellitus	0.000181	0.00105	CcSEcCtD
Ceftizoxime—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000179	0.00104	CcSEcCtD
Ceftizoxime—Vomiting—Ramipril—type 2 diabetes mellitus	0.000166	0.000962	CcSEcCtD
Ceftizoxime—Rash—Ramipril—type 2 diabetes mellitus	0.000165	0.000954	CcSEcCtD
Ceftizoxime—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000164	0.000953	CcSEcCtD
Ceftizoxime—Nausea—Ramipril—type 2 diabetes mellitus	0.000155	0.000899	CcSEcCtD
Ceftizoxime—Cefradine—CYP3A4—type 2 diabetes mellitus	2.87e-05	0.282	CrCbGaD
Ceftizoxime—Ceftriaxone—ALB—type 2 diabetes mellitus	2.04e-05	0.2	CrCbGaD
Ceftizoxime—Cephalexin—CYP3A4—type 2 diabetes mellitus	1.86e-05	0.183	CrCbGaD
Ceftizoxime—Cefalotin—ALB—type 2 diabetes mellitus	1.78e-05	0.175	CrCbGaD
Ceftizoxime—Cephalexin—ALB—type 2 diabetes mellitus	1.62e-05	0.159	CrCbGaD
